Baxter’s efforts this summer to correct high-risk issues with its infusion pumps has gotten more complicated. Last month, the company and the FDA alerted the public to a problem with the large-volume ...

Furthers Baxter’s continued innovation in medication delivery and management Integrates Baxter’s decades of leadership in infusion therapy with innovative digital health solutions to build on the ...

Baxter told customers that its Novum IQ syringe infusion pump may fail to deliver a complete infusion and shared “reinforced guidance” to mitigate the risk. After one or more downstream occlusion ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

Baxter International (NYSE:BAX) has recalled its Novum IQ Syringe Pumps over concerns that they may indicate an infusion is complete when it isn’t. The pumps are used to deliver fluids, medications ...

The FDA is spotlighting a new medical device correction effort at Baxter over its large-volume Novum IQ infusion pump, following reports of 79 serious injuries and two deaths linked to potential under ...

To date, there have been no reports of serious injury associated with this issue. Baxter International has issued an Urgent Medical Device Correction for the Novum IQ syringe infusion pump due to the ...

New addition to Baxter’s Evo IQ Infusion Platform complements on-market large volumetric pump, offering opportunity to further help personalize treatment Incorporates web-based Dose IQ Safety Software ...

Baxter International Inc. has scored FDA clearance for an infusion pump used to deliver small amounts of fluid at low rates, often in pediatric, neonatal and anesthesia care settings. The Novum Iq ...

Baxter International Inc. Thursday settled U.S. Justice Department allegations that two of its popular medication delivery pumps were flawed and violated federal law. In a 30-page agreement approved ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced CE marking and regulatory approval from Australia’s ...